Masimo Shares Outstanding 2007-2019 | MASI

Masimo shares outstanding history from 2007 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Masimo shares outstanding for the quarter ending December 31, 2019 were 0.057B, a 1.89% increase year-over-year.
  • Masimo 2019 shares outstanding were 0.057B, a 1.89% increase from 2018.
  • Masimo 2018 shares outstanding were 0.056B, a 0.3% increase from 2017.
  • Masimo 2017 shares outstanding were 0.056B, a 5.04% increase from 2016.
Masimo Annual Shares Outstanding
(Millions of Shares)
2019 57
2018 56
2017 56
2016 53
2015 54
2014 56
2013 57
2012 58
2011 61
2010 61
2009 60
2008 60
2007 81
2006 20
2005 13
Masimo Quarterly Shares Outstanding
(Millions of Shares)
Q4 2019 57
Q3 2019 57
Q2 2019 57
Q1 2019 57
Q4 2018 56
Q3 2018 56
Q2 2018 56
Q1 2018 55
Q4 2017 56
Q3 2017 56
Q2 2017 56
Q1 2017 56
Q4 2016 53
Q3 2016 54
Q2 2016 53
Q1 2016 52
Q4 2015 54
Q3 2015 54
Q2 2015 54
Q1 2015 54
Q4 2014 56
Q3 2014 55
Q2 2014 57
Q1 2014 58
Q4 2013 57
Q3 2013 57
Q2 2013 57
Q1 2013 58
Q4 2012 58
Q3 2012 58
Q2 2012 58
Q1 2012 59
Q4 2011 61
Q3 2011 61
Q2 2011 61
Q1 2011 61
Q4 2010 61
Q3 2010 61
Q2 2010 61
Q1 2010 60
Q4 2009 60
Q3 2009 60
Q2 2009 60
Q1 2009 57
Q4 2008 60
Q3 2008 60
Q2 2008 60
Q1 2008 55
Q4 2007 81
Q3 2007 71
Q2 2007 21
Q1 2007 17
Q3 2006 17
Q2 2006 20
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $8.929B $0.938B
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $123.970B 25.05
Intuitive Surgical (ISRG) United States $64.897B 48.44
Edwards Lifesciences (EW) United States $46.337B 39.78
ALCON INC (ALC) $30.849B 0.00
DexCom (DXCM) United States $25.486B 152.05
Olympus (OCPNY) Japan $24.747B 185.85
Fresenius Medical Care AG KGaA (FMS) Germany $23.524B 15.35
IDEXX Laboratories (IDXX) United States $22.139B 53.17
Teleflex (TFX) United States $16.009B 30.97
SONOVA HOLDING (SONVY) Switzerland $15.869B 0.00
STERIS (STE) Ireland $14.031B 29.92
Sysmex ADR (SSMXY) Japan $13.608B 36.63
Hologic (HOLX) United States $12.781B 19.65
Varian Medical Systems (VAR) United States $11.802B 27.46
SARTORIUS AG (SARTF) Germany $7.663B 68.08
ABIOMED (ABMD) United States $6.944B 36.60
Penumbra (PEN) United States $5.994B 177.00
Globus Medical (GMED) United States $4.906B 29.20
Integra LifeSciences Holdings (IART) United States $4.589B 19.83
Tandem Diabetes Care (TNDM) United States $4.571B 0.00
Nevro (NVRO) United States $4.423B 0.00
Elekta AB (EKTAY) Sweden $4.229B 32.56
Wright Medical Group (WMGI) Netherlands $3.901B 233.08
Integer Holdings (ITGR) United States $3.105B 20.22
LivaNova (LIVN) United Kingdom $3.035B 22.16
Cantel Medical (CMD) United States $2.811B 27.50
Nihon Kohden (NHNKY) Japan $2.742B 27.59
Glaukos (GKOS) United States $2.230B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.568B 30.69
Silk Road Medical (SILK) United States $1.396B 0.00
ShockWave Medical (SWAV) United States $1.160B 0.00
Veracyte (VCYT) United States $1.157B 0.00
Mesa Laboratories (MLAB) United States $1.123B 58.78
Inogen (INGN) United States $1.055B 44.75
Luminex (LMNX) United States $1.047B 0.00
Tactile Systems Technology (TCMD) United States $1.030B 96.64
CryoLife (CRY) United States $1.016B 83.87
Natus Medical (NTUS) United States $0.961B 22.56
OPKO Health (OPK) United States $0.919B 0.00
OrthoPediatrics (KIDS) United States $0.816B 0.00
Accelerate Diagnostics (AXDX) United States $0.783B 0.00
Intersect ENT (XENT) United States $0.726B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.695B 24.82
Pacific Biosciences Of California (PACB) United States $0.517B 0.00
AxoGen (AXGN) United States $0.516B 0.00
Quotient (QTNT) Switzerland $0.508B 0.00
Si-Bone (SIBN) United States $0.476B 0.00
AngioDynamics (ANGO) United States $0.443B 20.31
Alphatec Holdings (ATEC) United States $0.374B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.361B 10.91
Semler Scientific (SMLR) United States $0.341B 47.50
ViewRay (VRAY) United States $0.304B 0.00
RTI Surgical (RTIX) United States $0.299B 81.00
IRadimed (IRMD) United States $0.283B 33.31
SeaSpine Holdings (SPNE) United States $0.281B 0.00
Accuray (ARAY) United States $0.278B 0.00
CRH Medical (CRHM) Canada $0.259B 72.40
Stereotaxis (STXS) United States $0.254B 0.00
Restoration Robotics (VERO) Canada $0.245B 0.00
Fluidigm (FLDM) United States $0.233B 0.00
Sientra (SIEN) United States $0.232B 0.00
GenMark Diagnostics (GNMK) United States $0.211B 0.00
Spectral Diagnostics (EDTXF) Canada $0.120B 0.00
EDAP TMS S.A (EDAP) France $0.116B 30.77
Electromed (ELMD) United States $0.099B 27.12
Vermillion (VRML) United States $0.087B 0.00
MRI Interventions (CLPT) United States $0.079B 0.00
Second Sight Medical Products (EYES) United States $0.077B 0.00
Sensus Healthcare (SRTS) United States $0.067B 0.00
Apollo Endosurgery (APEN) United States $0.057B 0.00
ConforMIS (CFMS) United States $0.056B 0.00
Neuronetics (STIM) United States $0.056B 0.00
Bioanalytical Systems (BASI) United States $0.052B 0.00
Ekso Bionics Holdings (EKSO) United States $0.032B 0.00
TransEnterix (TRXC) United States $0.032B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.032B 0.00
T2 Biosystems (TTOO) United States $0.029B 0.00
Helius Medical Technologies (HSDT) United States $0.027B 0.00
Neovasc (NVCN) Canada $0.027B 0.00
Ra Medical Systems (RMED) United States $0.020B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.018B 0.00
DarioHealth (DRIO) Israel $0.018B 0.00
Xtant Medical Holdings (XTNT) United States $0.015B 0.00
Allied Healthcare Products (AHPI) United States $0.015B 0.00
American Shared Hospital Services (AMS) United States $0.014B 19.73
OBALON THERPTCS (OBLN) United States $0.014B 0.00
Nanovibronix (NAOV) United States $0.012B 0.00
ENDRA Life Sciences (NDRA) United States $0.010B 0.00
ReWalk Robotics (RWLK) Israel $0.010B 0.00
Avinger (AVGR) United States $0.010B 0.00
Dynatronics (DYNT) United States $0.010B 0.00
Lianluo Smart (LLIT) China $0.008B 0.00
Micron Solutions (MICR) United States $0.008B 0.00
InspireMD (NSPR) Israel $0.004B 0.00
Viveve Medical (VIVE) United States $0.002B 0.00
Sunshine Heart Inc (CHFS) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00